APA (7th ed.) Citation

KS, S., S, A., RB, D., S, V., & VVS, S. (2025). Clinical outcomes and safety study of CDK4/6 inhibitors in hormone-positive metastatic breast cancer - A real-world tertiary cancer center experience. Indian journal of cancer, 62(4), 541. https://doi.org/10.4103/ijc.ijc_643_23

Chicago Style (17th ed.) Citation

KS, Sandeep, Appachu S, Diwaker RB, Vivek S, and Simha VVS. "Clinical Outcomes and Safety Study of CDK4/6 Inhibitors in Hormone-positive Metastatic Breast Cancer - A Real-world Tertiary Cancer Center Experience." Indian Journal of Cancer 62, no. 4 (2025): 541. https://doi.org/10.4103/ijc.ijc_643_23.

MLA (9th ed.) Citation

KS, Sandeep, et al. "Clinical Outcomes and Safety Study of CDK4/6 Inhibitors in Hormone-positive Metastatic Breast Cancer - A Real-world Tertiary Cancer Center Experience." Indian Journal of Cancer, vol. 62, no. 4, 2025, p. 541, https://doi.org/10.4103/ijc.ijc_643_23.